Full Text
PHP33 The Use of Extreme Value Statistics in Assessing Long Decision Times in Public Funding of Medicines with New Molecules or Therapeutic Indications

Abstract

Authors

B. Vandewalle M.J. Silva S. Rabiais J. Almeida J. Félix

Back to Volume 15, Issue 7
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×